Skip to main content

Table 2 The levels of total cholesterol (TC), low- and high-density lipoprotein cholesterols (LDL-C & HDL-C), and triglycerides in serum of the control rats and those orally administrated PZA alone, NGN 1 h prior to PZA, and NGN alone, every day for 7, 14, 21 & 28 days. Data are displayed as mean (of 5 rats) ± standard error of mean

From: The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats

Parameter

Time

(days)

Experimental group

Treatment effect

Control

PZA

PZA + NGN

NGN

TC

(mg dL−1)

7

120.60 ± 0.76a

120.68 ± 0.43a

120.51 ± 1.13a

120.61 ± 0.78a

F3, 16 = 0.008, P = 0.999

14

120.55 ± 0.42a

122.68 ± 0.81a

120.72 ± 0.94a

120.69 ± 0.97a

F3, 16 = 1.554, P = 0.239

21

120.71 ± 0.78a

135.81 ± 1.78b*

120.60 ± 0.62a

120.79 ± 0.68a

F3, 16 = 49.12, P = 0.000

28

120.70 ± 1.01a

149.03 ± 1.56b*

120.79 ± 0.35a

120.66 ± 0.83a

F3, 16 = 187.9, P = 0.000

r

 + 0.94

 + 0.05

 + 0.02

 
 

Time effect

F3, 16 = 0.011, P = 0.998

F3, 16 = 107.08, P = 0.000

F3, 16 = 0.023, P = 0.995

F3, 16 = 0.008, P = 0.999

 

LDL-C

(mg dL−1)

7

60.66 ± 0.52a

62.30 ± 2.29a

60.83 ± 2.57a

60.90 ± 1.06a

F3, 16 = 0.175, P = 0.912

14

60.84 ± 0.66a

64.89 ± 1.95b

60.54 ± 0.75a

60.80 ± 0.81a

F3, 16 = 3.206, P = 0.051

21

60.72 ± 0.97a

79.03 ± 3.26b*

60.79 ± 0.86a

60.57 ± 1.10a

F3, 16 = 24.93, P = 0.000

28

60.70 ± 0.80a

98.11 ± 2.61b*

60.91 ± 0.56a

60.97 ± 0.33a

F3, 16 = 175.9, P = 0.000

r

 + 0.90

 + 0.02

 − 0.001

 
 

Time effect

F3, 16 = 0.011, P = 0.998

F3, 16 = 40.81, P = 0.000

F3, 16 = 0.012, P = 0.998

F3, 16 = 0.039, P = 0.989

 

HDL-C

(mg dL−1)

7

39.04 ± 0.35a

37.41 ± 2.17a

38.98 ± 1.61a

38.73 ± 0.53a

F3, 16 = 0.305, P = 0.821

14

38.82 ± 0.22b

36.34 ± 1.62a

39.32 ± 0.29b

38.85 ± 0.17b

F3, 16 = 2.609, P = 0.087

21

39.08 ± 0.65b

33.99 ± 1.85a

38.74 ± 0.59b

39.45 ± 0.76b

F3, 16 = 5.509, P = 0.009

28

39.04 ± 1.66b

22.29 ± 1.92a*

38.91 ± 0.59b

38.72 ± 0.46b

F3, 16 = 39.36, P = 0.000

r

 − 0.75

 − 0.05

 + 0.06

 
 

Time effect

F3, 16 = 0.016, P = 0.997

F3, 16 = 13.45, P = 0.000

F3, 16 = 0.071, P = 0.975

F3, 16 = 0.432, P = 0.733

 

TG

(mg dL−1)

7

104.55 ± 0.98a

104.89 ± 1.48a

103.48 ± 0.64a

104.91 ± 1.09a

F3, 16 = 0.379, P = 0.77

14

104.44 ± 0.80a

107.21 ± 2.10a

104.29 ± 1.43a

105.20 ± 1.50a

F3, 16 = 0.772, P = 0.527

21

104.57 ± 1.02a

113.93 ± 1.63b*

105.38 ± 1.39a

103.85 ± 1.27a

F3, 16 = 12.25, P = 0.000

28

104.86 ± 1.07a

143.15 ± 2.45b*

104.87 ± 1.68a

104.87 ± 1.00a

F3, 16 = 133.24, P = 0.000

r

 + 0.86

 + 0.21

 − 0.07

 
 

Time effect

F3, 16 = 0.034, P = 0.991

F3, 16 = 81.71, P = 0.000

F3, 16 = 0.365, P = 0.779

F3, 16 = 0.231, P = 0.874

 
  1. P < 0.05, P < 0.01, P < 0.000: represents significant effects. *: represent significant (P < 0.05) differences as compared to 7th day
  2. r: Pearson’s correlation coefficient of the studied parameters with the experimental time
  3. In the same row, according to Duncan’s test, means marked with the same small superscript letters are insignificantly different (P > 0.05), whereas those marked with different ones are significantly different (P < 0.05)